Skandinaviska Enskilda Banken Ab (Publ) Biocryst Pharmaceuticals Inc Transaction History
Skandinaviska Enskilda Banken Ab (Publ)
- $21.6 Billion
- Q4 2024
A detailed history of Skandinaviska Enskilda Banken Ab (Publ) transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Skandinaviska Enskilda Banken Ab (Publ) holds 114,063 shares of BCRX stock, worth $1.03 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
114,063
Previous 114,063
-0.0%
Holding current value
$1.03 Million
Previous $866,000
1.04%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding BCRX
# of Institutions
279Shares Held
169MCall Options Held
930KPut Options Held
1.03M-
Vanguard Group Inc Valley Forge, PA21.9MShares$198 Million0.0% of portfolio
-
Black Rock Inc. New York, NY20MShares$181 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY11.9MShares$107 Million1.3% of portfolio
-
Kynam Capital Management, LP Princeton, NJ9.09MShares$82.2 Million4.33% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY8.14MShares$73.7 Million1.52% of portfolio
About BIOCRYST PHARMACEUTICALS INC
- Ticker BCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,944,992
- Market Cap $1.68B
- Description
- BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...